z-logo
Premium
In vitro cytotoxic evaluation of some new heterocyclic sulfonamide derivatives
Author(s) -
Ghorab Mostafa M.,
AlSaid Mansour S.,
ElHossary Ebaa M.
Publication year - 2011
Publication title -
journal of heterocyclic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 59
eISSN - 1943-5193
pISSN - 0022-152X
DOI - 10.1002/jhet.619
Subject(s) - chemistry , sulfonamide , quinoline , carbonic anhydrase , moiety , in vitro , ehrlich ascites carcinoma , acetazolamide , in vivo , doxorubicin , stereochemistry , combinatorial chemistry , enzyme , biochemistry , organic chemistry , chemotherapy , medicine , microbiology and biotechnology , surgery , anesthesia , biology
Sulfonamide‐bearing compounds posses many types of biological activities and have been recently reported to show substantial antitumor activity in vitro and/or in vivo . There are a variety of mechanisms for the anticancer activity, and the most prominent mechanism is the inhibition of carbonic anhydrase isozymes. This work reports the synthesis of some new quinoline, pyrimido[4,5‐ b ]quinoline and 3,1‐oxazinoquinoline derivatives bearing a sulfonamide moiety. All the newly synthesized compounds were evaluated for their in vitro anticancer activity against Ehrlich ascites carcinoma cells. Compounds 10 , 13 , and 26 were the most active compounds with IC 50 values of 6.1 μ M , 6.8 μ M , and 6.4 μ M , respectively, and exhibited better activities than the reference drug doxorubicin (IC 50 = 68.1 μ M ). J. Heterocyclic Chem., 2011.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom